Monday, August 31, 2026
ExploreSearch
Via News
Markets

United Airlines Already 2% Down, Almost Two Hours Before The NASDAQ Open

ViaNews Editorial Team

December 23, 2020

United Airlines Already 2% Down, Almost Two Hours Before The NASDAQ Open

The Nasdaq Stock Market opens in less than two hours and United Airlines's premarket value is already 2.09% down.

Last session, the Nasdaq Stock Market ended with United Airlines falling 2.46% to $42.97. The Nasdaq Stock Market jumped 0.51% to $12,807.90, after two successive sessions in a row of losses, on what was a somewhat positive trend exchanging session.

United Airlines's last close was $44.06, 110.77% below its 52-week high of $90.57.

United Airlines's Revenue

Year-on-year quarterly revenue growth declined by 78.1%, now sitting on 22.83B for the twelve trailing months.

Previous days news about United Airlines

United Airlines issues fee waiver for travel to London. According to MarketWatch on Mon Dec 21, "United Airlines Holdings Inc. said Monday that it has is up 14.7% for the past 12 months."

Categories

Markets

Tags

Stock MarketStockWall StreetStock PriceStock Market NowNASDAQMarket SessionUALIXICThe Nasdaq Stock MarketStock Price DownUnited AirlinesPremarket
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com